The role of the ras oncogene in the formation of tumours.
A c-Ha-ras 1 oncogene, cloned from the EJ human bladder carcinoma cell line, was inserted into a shuttle vector carrying the selectable marker gene gpt that encodes the enzyme xanthine-guanine phosphoribosyl transferase. This construct, pSV2gptEJ, was transfected into NIH 3T3 cells by the calcium phosphate precipitation method and cells that had incorporated the plasmid were selected by growth in the presence of mycophenolic acid to which gpt confers resistance. A number of transfectant clones were tested for tumorigenicity by inoculation into nude mice. The take incidence was variable and the tumours arose only after a prolonged latent period. Many inocula produced no tumours. These results were consistent with the view that the tumours arose by selective overgrowth of minority cell populations. Cell lines were derived by explantation of these tumours and were back-selected in 2-thioxanthine, a cytotoxic analogue of the xanthine-guanine phosphoribosyl transferase substrate. Five clones were obtained that did not express detectable levels of the c-Ha-ras 1 oncogene product, p21ras. All of them showed a less-transformed morphology than the transfected NIH 3T3 cells from which they originated. Nonetheless three of these clones were found to be tumorigenic at all sites tested. This finding demonstrates that once tumorigenic variants have been selected from the ras-transformed cells, continued production of the p21ras protein is not necessary for the maintenance of tumorigenicity. Cytogenetic analysis revealed that the transfection procedure itself introduced major and stable perturbations of the genome of the transfected cells and confirmed that tumours were produced by selective overgrowth of variants with a chromosome constitution palpably different from that of the majority of the cells injected. In the light of the complex background of genomic changes produced in NIH 3T3 cells by transfection with the c-Ha-ras 1 oncogene, no conclusion can be drawn in genetic terms concerning its dominance.
Gilbert
P X
PX
Sir William Dunn School of Pathology, University of Oxford, UK.
Harris
H
H
D000818:Animals; D014408:Biomarkers, Tumor; D015197:Carcinogenicity Tests; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D011905:Genes, ras; D005822:Genetic Vectors; D007621:Karyotyping; D051379:Mice; D009369:Neoplasms / Q000235:genetics*; D010957:Plasmids; D013892:Thioxanthenes / Q000494:pharmacology; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000187:drug effects
D014408:Biomarkers, Tumor; D013892:Thioxanthenes; C060355:2-thioxanthene